CA3228060A1 - Crystal forms and methods of synthesis of (2r, 6r)-hydroxynorketamine and (2s, 6s)-hydroxynorketamine - Google Patents

Crystal forms and methods of synthesis of (2r, 6r)-hydroxynorketamine and (2s, 6s)-hydroxynorketamine Download PDF

Info

Publication number
CA3228060A1
CA3228060A1 CA3228060A CA3228060A CA3228060A1 CA 3228060 A1 CA3228060 A1 CA 3228060A1 CA 3228060 A CA3228060 A CA 3228060A CA 3228060 A CA3228060 A CA 3228060A CA 3228060 A1 CA3228060 A1 CA 3228060A1
Authority
CA
Canada
Prior art keywords
formula
compound
hydroxynorketamine
norketamine
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3228060A
Other languages
English (en)
French (fr)
Inventor
Craig Thomas
Patrick Morris
Carlos Zarate
Ruin Moaddel
Todd GOULD
Panos ZANOS
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Maryland Baltimore
US Department of Health and Human Services
Original Assignee
University of Maryland Baltimore
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Maryland Baltimore, US Department of Health and Human Services filed Critical University of Maryland Baltimore
Publication of CA3228060A1 publication Critical patent/CA3228060A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/20—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C221/00—Preparation of compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/04—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups from amines with formation of carbamate groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/06—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA3228060A 2016-03-25 2017-03-27 Crystal forms and methods of synthesis of (2r, 6r)-hydroxynorketamine and (2s, 6s)-hydroxynorketamine Pending CA3228060A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662313309P 2016-03-25 2016-03-25
US62/313,309 2016-03-25
CA3018959A CA3018959C (en) 2016-03-25 2017-03-27 Crystal forms and methods of synthesis of (2r, 6r)-hydroxynorketamine and (2s, 6s)-hydroxynorketamine

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA3018959A Division CA3018959C (en) 2016-03-25 2017-03-27 Crystal forms and methods of synthesis of (2r, 6r)-hydroxynorketamine and (2s, 6s)-hydroxynorketamine

Publications (1)

Publication Number Publication Date
CA3228060A1 true CA3228060A1 (en) 2017-09-28

Family

ID=58503714

Family Applications (2)

Application Number Title Priority Date Filing Date
CA3228060A Pending CA3228060A1 (en) 2016-03-25 2017-03-27 Crystal forms and methods of synthesis of (2r, 6r)-hydroxynorketamine and (2s, 6s)-hydroxynorketamine
CA3018959A Active CA3018959C (en) 2016-03-25 2017-03-27 Crystal forms and methods of synthesis of (2r, 6r)-hydroxynorketamine and (2s, 6s)-hydroxynorketamine

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA3018959A Active CA3018959C (en) 2016-03-25 2017-03-27 Crystal forms and methods of synthesis of (2r, 6r)-hydroxynorketamine and (2s, 6s)-hydroxynorketamine

Country Status (7)

Country Link
US (3) US10919842B2 (enExample)
EP (1) EP3433230A1 (enExample)
JP (3) JP7603368B2 (enExample)
CN (2) CN115108927A (enExample)
AU (1) AU2017238859B2 (enExample)
CA (2) CA3228060A1 (enExample)
WO (1) WO2017165878A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016288188B2 (en) 2015-06-27 2021-08-05 Shenox Pharmaceuticals, Llc Ketamine transdermal delivery system
AU2017238859B2 (en) 2016-03-25 2021-02-18 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 6S)-hydroxynorketamine
WO2017180589A1 (en) * 2016-04-11 2017-10-19 Auspex Pharmaceuticals, Inc. Deuterated ketamine derivatives
CN110343050B (zh) * 2018-04-04 2021-09-24 上海键合医药科技有限公司 芳香类化合物及其制备方法和用途
CA3102387A1 (en) * 2018-06-04 2019-12-12 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Process for synthesis and purification of (2r,6r)-hydroxynorketamine
CN112299972B (zh) * 2019-08-02 2023-03-14 扬子江药业集团有限公司 一种高纯度盐酸艾司氯胺酮酮体的制备方法
WO2021101867A1 (en) 2019-11-18 2021-05-27 The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services Salts of (2r, 6r)-hydroxynorketamine, their crystal forms, and methods of making the same
US12466785B2 (en) 2020-08-31 2025-11-11 Shenzhen Ruijian Biotechnology Co., Ltd Long-acting low-addiction HNK derivative and preparation method therefor
CN112521358B (zh) * 2020-08-31 2021-10-08 深圳瑞健生物科技有限公司 一种长效低成瘾性hnk衍生物在制备药物中的应用
CN112516130B (zh) * 2020-08-31 2022-01-04 深圳瑞健生物科技有限公司 一种长效低成瘾性化合物在制备药物中的应用
WO2022041172A1 (zh) * 2020-08-31 2022-03-03 深圳瑞健生物科技有限公司 一种长效低成瘾性化合物在制备药物中的应用
WO2022041175A1 (zh) * 2020-08-31 2022-03-03 深圳瑞健生物科技有限公司 一种长效低成瘾性hnk衍生物在制备药物中的应用
CN112521357B (zh) * 2020-08-31 2021-10-08 深圳瑞健生物科技有限公司 一种长效低成瘾性hnk衍生物及其制备方法
EP4148048B1 (en) * 2020-08-31 2025-04-09 Shenzen Ruijian Biotechnology Co., Ltd. Long-acting low-addiction hnk derivative and preparation method therefor
CN112521295B (zh) * 2020-08-31 2021-10-08 深圳瑞健生物科技有限公司 一种长效低成瘾性化合物及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE435499B (sv) * 1974-12-13 1984-10-01 Merck & Co Inc Diastereomert salt av s-1-t-butylamino-2,3-dihydroxipropan
US20070185346A1 (en) 2006-02-03 2007-08-09 Vaidya Niteen A Kit for automated resolving agent selection and method thereof
US8710070B2 (en) * 2008-03-27 2014-04-29 University Of Kentucky Research Foundation Opioid-ketamine and norketamine codrug combinations for pain management
CN104395283A (zh) * 2011-10-14 2015-03-04 美国政府健康及人类服务部 (2r,6r)-羟基去甲氯胺酮、(s)-脱氢去甲氯胺酮以及(r,s)-氯胺酮的其他立体异构脱氢和羟基化代谢物在治疗忧郁症和神经性疼痛中的应用
WO2014020155A1 (en) * 2012-08-02 2014-02-06 Clinpharm Reform Gmbh Oral transmucosal adminstration forms of s-ketamine
EA201590697A1 (ru) * 2012-10-08 2015-09-30 Окленд Юнисервисиз Лимитед Производные кетамина
US9096537B1 (en) * 2014-12-31 2015-08-04 Mahesh Kandula Compositions and methods for the treatment of mucositis
AU2017238859B2 (en) 2016-03-25 2021-02-18 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 6S)-hydroxynorketamine
AU2017238858A1 (en) * 2016-03-25 2018-10-18 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods of using (2R, 6R)-hydroxynorketamine and (2S, 6S)-hydroxynorketamine in the treatment of depression, anxiety, anhedonia, fatigue, suicidal ideation, and post traumatic stress disorders
EP3505509A1 (en) 2017-12-29 2019-07-03 Université de Liège Methods for the preparation of arylcycloalkylamine derivatives

Also Published As

Publication number Publication date
CN109311801B (zh) 2022-07-26
US20230192594A1 (en) 2023-06-22
CN109311801A (zh) 2019-02-05
CN115108927A (zh) 2022-09-27
AU2017238859B2 (en) 2021-02-18
JP2024015334A (ja) 2024-02-01
AU2017238859A1 (en) 2018-10-18
US10919842B2 (en) 2021-02-16
JP7379567B2 (ja) 2023-11-14
JP7603368B2 (ja) 2024-12-20
EP3433230A1 (en) 2019-01-30
CA3018959A1 (en) 2017-09-28
US11613514B2 (en) 2023-03-28
US20210139411A1 (en) 2021-05-13
US12473251B2 (en) 2025-11-18
CA3018959C (en) 2024-03-12
WO2017165878A1 (en) 2017-09-28
US20190135732A1 (en) 2019-05-09
JP2022069595A (ja) 2022-05-11
JP2019510768A (ja) 2019-04-18

Similar Documents

Publication Publication Date Title
US11613514B2 (en) Crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 6S)-hydroxynorketamine
ES2333488T3 (es) Procedimiento para la preparacion de asenapina y productos intermedios usados en dicho proceso.
Overman et al. Use of aza-Cope rearrangement-Mannich cyclization reactions to achieve a general entry to Melodinus and Aspidosperma alkaloids. Stereocontrolled total syntheses of (.+-.)-deoxoapodine,(.+-.)-meloscine, and (.+-.)-epimeloscine and a formal synthesis of (.+-.)-1-acetylaspidoalbidine
US20040230054A1 (en) Cyclic sulfonamides for inhibition of gamma-secretase
JP3740050B2 (ja) ケトンの還元用キラル触媒とその製法
NZ747061A (en) Prodrug of amino acid derivative
JPH0819085B2 (ja) １−（フエニル）−１−ヒドロキシ−２−アミノ−３−フルオロプロパン誘導体製造用中間体
CN104203915B (zh) (3，4‑二氯‑苯基)‑((s)‑3‑丙基‑吡咯烷‑3‑基)‑甲酮盐酸盐和制造方法
JP4742239B2 (ja) ビシクロ［３．１．０］ヘキサン誘導体およびその中間体の製造方法
EP1856124B1 (en) New synthesis of a camptothecin subunit
JP2007506794A (ja) ナルウェジンアミド誘導体の分割
Oppenländer et al. Synthesis, Reactivity, and Application as Chiral Auxiliaries of the novel (3R)‐and (3S)‐4, 5‐dihydro‐3‐hydroxy‐4, 4, 5, 5‐tetramethyl‐3‐phenylfuran‐2 (3H)‐ones in the Paterno‐Büchi reaction
AU2013286077B2 (en) Process for preparing enantiomerically enriched oxamides
JPH08231469A (ja) シクロペンタンカルボン酸誘導体及びその製造法
CN121913944A (zh) 用于合成二氮杂二环[6.2.0]癸烷相关化合物的方法
KR20020010931A (ko) 의약품 중간체 화합물의 제조 방법
Couture et al. A new synthetic route to the previously unattainable 2-arylpyrido [2, 3-b][1, 5] thiazepin-4 (5H)-ones
Cutter Step-efficient asymmetric approaches to saturated nitrogen heterocycles
WO2007037303A1 (ja) テトラ置換－５－アザスピロ[２．４]へプタン誘導体の製法およびその光学活性中間体
Purewal Dearomatising cyclisations: Application in synthesis
JP2007533671A (ja) クロピドグレルの立体選択的な製造方法
WO2018025295A1 (en) Concise process for preparing 3-pyrrolidine carboxylic acid derivatives
JPH09506618A (ja) スピロ環式ラクタムの製造方法
MXPA06005039A (en) Processes for preparing bicyclo [3.1.0]hexane derivatives, and intermediates thereto
JPWO2000078722A1 (ja) 医薬品中間体化合物の製造方法

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20240202

D15 Examination report completed

Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT

Effective date: 20250207

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 8TH ANNIV.) - STANDARD

Year of fee payment: 8

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250321

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20250321

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250321

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - RESPONSE TO EXAMINER'S REQUISITION

Effective date: 20250603

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT

Effective date: 20250604

P13 Application amended

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED

Effective date: 20250604

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20250604